{
    "title": "Novo Nordisk adding in-house fill-finish capacity for Wegovy's European pen, Ozempic",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12702155/Novo-Nordisk-adding-house-finish-capacity-Wegovys-European-pen-Ozempic.html",
    "date": "2023-11-02",
    "keywords": [
        "capacity",
        "europe",
        "drug",
        "ozempic",
        "company",
        "year",
        "production",
        "knudsen",
        "maggie",
        "fick",
        "inhouse",
        "manufacturing",
        "injection",
        "novo",
        "end",
        "contract",
        "expansion",
        "wegovy",
        "api",
        "jacob",
        "nordisk",
        "version",
        "executive",
        "danish",
        "drugmaker",
        "record",
        "operating",
        "profit",
        "quarter",
        "thursday",
        "success",
        "krone",
        "meet",
        "demand",
        "officer",
        "munk",
        "companys",
        "ceo",
        "term",
        "process",
        "fillfinish",
        "type",
        "work",
        "investment",
        "challenge",
        "competition",
        "lillys",
        "treatment",
        "mounjaro",
        "approval",
        "loss",
        "july",
        "quality",
        "novos",
        "thermo",
        "fisher",
        "track",
        "online",
        "cartridge",
        "pen",
        "device",
        "spending",
        "semaglutide",
        "ingredient",
        "rybelsus",
        "kalundborg",
        "carolina",
        "editing",
        "josephine",
        "mason",
        "fenton"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}